Banks Tighten Screws on FS KKR Capital as Sponsor and Insiders Stage a Counteroffensive

The private credit lender FS KKR Capital is weathering a perfect storm of deteriorating fundamentals and shrinking access to borrowed money, but a trio of moves by its controlling shareholder has offered a floor for the stock. A banking syndicate led by JPMorgan has slashed the company's revolving credit facility by $648 million, clamping down on liquidity just as the portfolio's credit quality takes a hit. In response, KKR Alternative Assets and a KKR subsidiary have pledged up to $300 million in direct capital, while management and outside institutions have snapped up shares at depressed levels.

The quarterly numbers that prompted the banks to act were grim. For the first quarter of 2026, FS KKR Capital posted a net loss of $1.57 per share, widening sharply from a loss of $0.41 in the prior quarter. Net investment income landed at $0.42 per share, two cents shy of the consensus estimate. Revenue of $304 million undershot forecasts by about $13 million. The net asset value crumbled to $18.83 per share from $20.89 at year-end, a drop of nearly 10%. Two credits in particular—software provider Medallia and dental services firm Affordable Care—stopped making interest payments, pushing the cost-basis share of non-accrual investments from 5.5% to 8.1%. On performing loans, the portfolio yield slid to 9.7%.

That deterioration triggered a substantial reset of the company's borrowing capacity. The asset-based facility, originally committed at $4.7 billion, was trimmed to approximately $4.05 billion. To stay compliant, the minimum equity requirement fell to $3.75 billion from around $5.05 billion. Lenders that continued to participate saw their margins widen to a range of 0.775%–1.9%, making drawn funds more expensive. On a pro-forma basis, FS KKR Capital put its liquid resources at $2.3 billion as of March 31—a figure that includes undrawn capacity, cash, and net receivables.

Should investors sell immediately? Or is it worth buying FS KKR Capital?

Enter KKR. The sponsor's alternative-assets arm agreed to buy $150 million of newly issued cumulative convertible preferred stock, carrying a liquidation preference of $25 per share and paying an initial 5% annual dividend. The preferreds convert into common equity after six months at an initial conversion price of $18.83. Separately, a KKR subsidiary launched a tender offer for up to $150 million of common stock at a fixed price of $11.00 per share, with an expiration date of June 9, 2026. The board endorsed the offer but offered no recommendation to shareholders. On top of that, KKR waived its portion of the subordinated incentive fee effective this quarter—a move that directly shores up net investment income and, by extension, the company's ability to maintain its payout. The board also authorized a $300 million buyback program, slated to begin after the tender offer concludes.

That payout has become a magnet for income-focused investors. FS KKR Capital held its quarterly dividend steady at $0.42 per share, translating to a yield of roughly 15% based on the current stock price. For the current quarter, the company has declared another $0.42 distribution, payable on July 2, 2026 to holders of record on June 17. Yet the sheer magnitude of the yield has raised questions about sustainability, given the earnings shortfall and the NAV erosion.

In a sharp contrast to the credit tightening, institutional and insider buying has accelerated. Northwestern Mutual Wealth Management expanded its stake by more than 55,000%, to approximately 7.74 million shares. Insider Daniel Pietrzak, meanwhile, added 5,000 shares at $11.25 apiece. The stock, which closed the week at €9.51 (roughly $10.27), has lost 25.4% since the start of the year and nearly 50% over the past 12 months—more than 52% below its 52-week high. Despite the slide, analysts remain cautious: seven rate the stock a "hold," one recommends "sell," and the average price target sits at $10.58. On a technical basis, the relative strength index of 68 suggests the shares have built some near-term upside momentum.

Looking ahead, FS KKR Capital intends to rotate its portfolio and slim down its balance sheet over the next 18 months. Roughly 90% of its liabilities do not mature until 2028 or later, giving the firm a meaningful window to work through problem credits and try to stabilize its net asset value. For now, the combination of a slashed credit line and a generous—but pressurized—dividend has created a high-stakes tug-of-war between the forces pulling the company down and those trying to rescue it.

Ad

FS KKR Capital Stock: New Analysis - 18 May

Fresh FS KKR Capital information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated FS KKR Capital analysis...

en | US3026352068 | BANKS | boerse | 69366753 |